0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ocular Genetic Diagnostic Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-17X10569
Home | Market Reports | Health| Vision Care
Global Ocular Genetic Diagnostic Market Research Report 2022
BUY CHAPTERS

Global Ocular Genetic Diagnostic Market Research Report 2025

Code: QYRE-Auto-17X10569
Report
February 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ocular Genetic Diagnostic Market Size

The global market for Ocular Genetic Diagnostic was valued at US$ 1070 million in the year 2024 and is projected to reach a revised size of US$ 1579 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Ocular Genetic Diagnostic Market

Ocular Genetic Diagnostic Market

There are around 5,000 genetic disorders and syndromes that affect the mankind. Of this vast number, at least one third of them are related to eyes. With the recent advancements in molecular genetics and various sequencing methods, a wide array of various hereditary eye diseases have been discovered.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Genetic Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Genetic Diagnostic.
The Ocular Genetic Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Genetic Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Genetic Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ocular Genetic Diagnostic Market Report

Report Metric Details
Report Name Ocular Genetic Diagnostic Market
Accounted market size in year US$ 1070 million
Forecasted market size in 2031 US$ 1579 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Next-generation Sequencing (NGS)
  • Multiplex Ligation-Dependent Probe Amplification (MLPA)
  • Fragment Analysis PCR for Repeat Expansion Analysis
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen, Medgenome, Sankara Nethralaya, Fulgent Genetics, GeneDx, Devyser, Invitae Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Ocular Genetic Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Ocular Genetic Diagnostic Market growing?

Ans: The Ocular Genetic Diagnostic Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Ocular Genetic Diagnostic Market size in 2031?

Ans: The Ocular Genetic Diagnostic Market size in 2031 will be US$ 1579 million.

Who are the main players in the Ocular Genetic Diagnostic Market report?

Ans: The main players in the Ocular Genetic Diagnostic Market are Quest Diagnostics, Columbia ophthalmology, Centogene, DBGen, Medgenome, Sankara Nethralaya, Fulgent Genetics, GeneDx, Devyser, Invitae Corporation

What are the Application segmentation covered in the Ocular Genetic Diagnostic Market report?

Ans: The Applications covered in the Ocular Genetic Diagnostic Market report are Hospitals, Diagnostic Laboratories, Academic and Research Centers, Others

What are the Type segmentation covered in the Ocular Genetic Diagnostic Market report?

Ans: The Types covered in the Ocular Genetic Diagnostic Market report are Next-generation Sequencing (NGS), Multiplex Ligation-Dependent Probe Amplification (MLPA), Fragment Analysis PCR for Repeat Expansion Analysis

Recommended Reports

Ophthalmic Drugs

Ocular Diagnostics

Genetic Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Genetic Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Multiplex Ligation-Dependent Probe Amplification (MLPA)
1.2.4 Fragment Analysis PCR for Repeat Expansion Analysis
1.3 Market by Application
1.3.1 Global Ocular Genetic Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ocular Genetic Diagnostic Market Perspective (2020-2031)
2.2 Global Ocular Genetic Diagnostic Growth Trends by Region
2.2.1 Global Ocular Genetic Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ocular Genetic Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Ocular Genetic Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Ocular Genetic Diagnostic Market Dynamics
2.3.1 Ocular Genetic Diagnostic Industry Trends
2.3.2 Ocular Genetic Diagnostic Market Drivers
2.3.3 Ocular Genetic Diagnostic Market Challenges
2.3.4 Ocular Genetic Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ocular Genetic Diagnostic Players by Revenue
3.1.1 Global Top Ocular Genetic Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Ocular Genetic Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Ocular Genetic Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ocular Genetic Diagnostic Revenue
3.4 Global Ocular Genetic Diagnostic Market Concentration Ratio
3.4.1 Global Ocular Genetic Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Genetic Diagnostic Revenue in 2024
3.5 Global Key Players of Ocular Genetic Diagnostic Head office and Area Served
3.6 Global Key Players of Ocular Genetic Diagnostic, Product and Application
3.7 Global Key Players of Ocular Genetic Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ocular Genetic Diagnostic Breakdown Data by Type
4.1 Global Ocular Genetic Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Type (2026-2031)
5 Ocular Genetic Diagnostic Breakdown Data by Application
5.1 Global Ocular Genetic Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Ocular Genetic Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ocular Genetic Diagnostic Market Size (2020-2031)
6.2 North America Ocular Genetic Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ocular Genetic Diagnostic Market Size by Country (2020-2025)
6.4 North America Ocular Genetic Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ocular Genetic Diagnostic Market Size (2020-2031)
7.2 Europe Ocular Genetic Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ocular Genetic Diagnostic Market Size by Country (2020-2025)
7.4 Europe Ocular Genetic Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ocular Genetic Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Ocular Genetic Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ocular Genetic Diagnostic Market Size (2020-2031)
9.2 Latin America Ocular Genetic Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ocular Genetic Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Ocular Genetic Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ocular Genetic Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Ocular Genetic Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Ocular Genetic Diagnostic Introduction
11.1.4 Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.1.5 Quest Diagnostics Recent Development
11.2 Columbia ophthalmology
11.2.1 Columbia ophthalmology Company Details
11.2.2 Columbia ophthalmology Business Overview
11.2.3 Columbia ophthalmology Ocular Genetic Diagnostic Introduction
11.2.4 Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.2.5 Columbia ophthalmology Recent Development
11.3 Centogene
11.3.1 Centogene Company Details
11.3.2 Centogene Business Overview
11.3.3 Centogene Ocular Genetic Diagnostic Introduction
11.3.4 Centogene Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.3.5 Centogene Recent Development
11.4 DBGen
11.4.1 DBGen Company Details
11.4.2 DBGen Business Overview
11.4.3 DBGen Ocular Genetic Diagnostic Introduction
11.4.4 DBGen Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.4.5 DBGen Recent Development
11.5 Medgenome
11.5.1 Medgenome Company Details
11.5.2 Medgenome Business Overview
11.5.3 Medgenome Ocular Genetic Diagnostic Introduction
11.5.4 Medgenome Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.5.5 Medgenome Recent Development
11.6 Sankara Nethralaya
11.6.1 Sankara Nethralaya Company Details
11.6.2 Sankara Nethralaya Business Overview
11.6.3 Sankara Nethralaya Ocular Genetic Diagnostic Introduction
11.6.4 Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.6.5 Sankara Nethralaya Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Ocular Genetic Diagnostic Introduction
11.7.4 Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.7.5 Fulgent Genetics Recent Development
11.8 GeneDx
11.8.1 GeneDx Company Details
11.8.2 GeneDx Business Overview
11.8.3 GeneDx Ocular Genetic Diagnostic Introduction
11.8.4 GeneDx Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.8.5 GeneDx Recent Development
11.9 Devyser
11.9.1 Devyser Company Details
11.9.2 Devyser Business Overview
11.9.3 Devyser Ocular Genetic Diagnostic Introduction
11.9.4 Devyser Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.9.5 Devyser Recent Development
11.10 Invitae Corporation
11.10.1 Invitae Corporation Company Details
11.10.2 Invitae Corporation Business Overview
11.10.3 Invitae Corporation Ocular Genetic Diagnostic Introduction
11.10.4 Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2020-2025)
11.10.5 Invitae Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Ocular Genetic Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Next-generation Sequencing (NGS)
 Table 3. Key Players of Multiplex Ligation-Dependent Probe Amplification (MLPA)
 Table 4. Key Players of Fragment Analysis PCR for Repeat Expansion Analysis
 Table 5. Global Ocular Genetic Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Ocular Genetic Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Ocular Genetic Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Ocular Genetic Diagnostic Market Share by Region (2020-2025)
 Table 9. Global Ocular Genetic Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Ocular Genetic Diagnostic Market Share by Region (2026-2031)
 Table 11. Ocular Genetic Diagnostic Market Trends
 Table 12. Ocular Genetic Diagnostic Market Drivers
 Table 13. Ocular Genetic Diagnostic Market Challenges
 Table 14. Ocular Genetic Diagnostic Market Restraints
 Table 15. Global Ocular Genetic Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Ocular Genetic Diagnostic Market Share by Players (2020-2025)
 Table 17. Global Top Ocular Genetic Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Genetic Diagnostic as of 2024)
 Table 18. Ranking of Global Top Ocular Genetic Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Ocular Genetic Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Ocular Genetic Diagnostic, Headquarters and Area Served
 Table 21. Global Key Players of Ocular Genetic Diagnostic, Product and Application
 Table 22. Global Key Players of Ocular Genetic Diagnostic, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Ocular Genetic Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Ocular Genetic Diagnostic Revenue Market Share by Type (2020-2025)
 Table 26. Global Ocular Genetic Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Ocular Genetic Diagnostic Revenue Market Share by Type (2026-2031)
 Table 28. Global Ocular Genetic Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Ocular Genetic Diagnostic Revenue Market Share by Application (2020-2025)
 Table 30. Global Ocular Genetic Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Ocular Genetic Diagnostic Revenue Market Share by Application (2026-2031)
 Table 32. North America Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Ocular Genetic Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Ocular Genetic Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Ocular Genetic Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Ocular Genetic Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Ocular Genetic Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Ocular Genetic Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Ocular Genetic Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Ocular Genetic Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Ocular Genetic Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Ocular Genetic Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Quest Diagnostics Company Details
 Table 48. Quest Diagnostics Business Overview
 Table 49. Quest Diagnostics Ocular Genetic Diagnostic Product
 Table 50. Quest Diagnostics Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 51. Quest Diagnostics Recent Development
 Table 52. Columbia ophthalmology Company Details
 Table 53. Columbia ophthalmology Business Overview
 Table 54. Columbia ophthalmology Ocular Genetic Diagnostic Product
 Table 55. Columbia ophthalmology Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 56. Columbia ophthalmology Recent Development
 Table 57. Centogene Company Details
 Table 58. Centogene Business Overview
 Table 59. Centogene Ocular Genetic Diagnostic Product
 Table 60. Centogene Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 61. Centogene Recent Development
 Table 62. DBGen Company Details
 Table 63. DBGen Business Overview
 Table 64. DBGen Ocular Genetic Diagnostic Product
 Table 65. DBGen Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 66. DBGen Recent Development
 Table 67. Medgenome Company Details
 Table 68. Medgenome Business Overview
 Table 69. Medgenome Ocular Genetic Diagnostic Product
 Table 70. Medgenome Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 71. Medgenome Recent Development
 Table 72. Sankara Nethralaya Company Details
 Table 73. Sankara Nethralaya Business Overview
 Table 74. Sankara Nethralaya Ocular Genetic Diagnostic Product
 Table 75. Sankara Nethralaya Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 76. Sankara Nethralaya Recent Development
 Table 77. Fulgent Genetics Company Details
 Table 78. Fulgent Genetics Business Overview
 Table 79. Fulgent Genetics Ocular Genetic Diagnostic Product
 Table 80. Fulgent Genetics Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 81. Fulgent Genetics Recent Development
 Table 82. GeneDx Company Details
 Table 83. GeneDx Business Overview
 Table 84. GeneDx Ocular Genetic Diagnostic Product
 Table 85. GeneDx Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 86. GeneDx Recent Development
 Table 87. Devyser Company Details
 Table 88. Devyser Business Overview
 Table 89. Devyser Ocular Genetic Diagnostic Product
 Table 90. Devyser Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 91. Devyser Recent Development
 Table 92. Invitae Corporation Company Details
 Table 93. Invitae Corporation Business Overview
 Table 94. Invitae Corporation Ocular Genetic Diagnostic Product
 Table 95. Invitae Corporation Revenue in Ocular Genetic Diagnostic Business (2020-2025) & (US$ Million)
 Table 96. Invitae Corporation Recent Development
 Table 97. Research Programs/Design for This Report
 Table 98. Key Data Information from Secondary Sources
 Table 99. Key Data Information from Primary Sources
 Table 100. Authors List of This Report


List of Figures
 Figure 1. Ocular Genetic Diagnostic Picture
 Figure 2. Global Ocular Genetic Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ocular Genetic Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Next-generation Sequencing (NGS) Features
 Figure 5. Multiplex Ligation-Dependent Probe Amplification (MLPA) Features
 Figure 6. Fragment Analysis PCR for Repeat Expansion Analysis Features
 Figure 7. Global Ocular Genetic Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Ocular Genetic Diagnostic Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Diagnostic Laboratories Case Studies
 Figure 11. Academic and Research Centers Case Studies
 Figure 12. Others Case Studies
 Figure 13. Ocular Genetic Diagnostic Report Years Considered
 Figure 14. Global Ocular Genetic Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Ocular Genetic Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Ocular Genetic Diagnostic Market Share by Region: 2024 VS 2031
 Figure 17. Global Ocular Genetic Diagnostic Market Share by Players in 2024
 Figure 18. Global Top Ocular Genetic Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Genetic Diagnostic as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Ocular Genetic Diagnostic Revenue in 2024
 Figure 20. North America Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Ocular Genetic Diagnostic Market Share by Country (2020-2031)
 Figure 22. United States Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Ocular Genetic Diagnostic Market Share by Country (2020-2031)
 Figure 26. Germany Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Ocular Genetic Diagnostic Market Share by Region (2020-2031)
 Figure 34. China Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Ocular Genetic Diagnostic Market Share by Country (2020-2031)
 Figure 42. Mexico Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Ocular Genetic Diagnostic Market Share by Country (2020-2031)
 Figure 46. Turkey Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Ocular Genetic Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Quest Diagnostics Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 50. Columbia ophthalmology Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 51. Centogene Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 52. DBGen Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 53. Medgenome Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 54. Sankara Nethralaya Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 55. Fulgent Genetics Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 56. GeneDx Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 57. Devyser Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 58. Invitae Corporation Revenue Growth Rate in Ocular Genetic Diagnostic Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart